Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaturvedi, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chaturvedi, S.
Related Collections
Right arrow Carotid Stenosis
Right arrow Carotid endarterectomy
Right arrow Transient Ischemic Attacks

(Stroke. 2000;31:983.)
© 2000 American Heart Association, Inc.


Letters to the Editor

Supplement to the AHA Guidelines for the Management of Transient Ischemic Attacks

Seemant Chaturvedi, MD

Department of Neurology, Wayne State University, Detroit, Michigan

To the Editor:

I read with interest the recent supplement to the guidelines on management of patients with transient ischemic attacks.1 However, with regard to carotid endarterectomy (CE), I was disappointed that Albers et al made no attempt to interpret the clinical trial results in the context of real-world surgical performance.

For example, in the updated section on CE for 50% to 69% symptomatic stenosis, the authors state that symptomatic patients with 50% to 69% benefit from surgery and that these patients should be considered for CE. However, should clinicians conclude that because patients in the surgical arm of the North American Symptomatic Carotid Endarterectomy Trial (NASCET) had a marginal statistically significant benefit (P=0.045) that this result is clinically meaningful and that this can be routinely achieved in clinical practice?

One must keep in mind that the benefit of surgery in the 50% to 69% group was very modest. For the important clinical outcome of disabling, ipsilateral stroke, the absolute difference between the medical and surgical groups was only 4.4% at 5 years, or less than 1% per year.2 This modest result was achieved in the ideal setting of low-risk patients being operated on by surgeons screened for their excellence. In NASCET as a whole, the perioperative mortality was 1.1% and the stroke and death rate was 6.5%.

In terms of the real world, Wennberg et al3 analyzed CE results in over 100 000 Medicare beneficiaries in 1992–1993 and found the perioperative mortality at an average volume hospital . . . [Full Text of this Article]





This article has been cited by other articles:


Home page
Neurorehabil Neural RepairHome page
K.-c. Lin, Y.-f. Chang, C.-y. Wu, and Y.-a. Chen
Effects of Constraint-Induced Therapy Versus Bilateral Arm Training on Motor Performance, Daily Functions, and Quality of Life in Stroke Survivors
Neurorehabil Neural Repair, June 1, 2009; 23(5): 441 - 448.
[Abstract] [PDF]


Home page
Clin RehabilHome page
C. Brogardh and B. H Sjolund
Constraint-induced movement therapy in patients with stroke: a pilot study on effects of small group training and of extended mitt use
Clinical Rehabilitation, March 1, 2006; 20(3): 218 - 227.
[Abstract] [PDF]